Ginkgo Bioworks Holdings DNA
NYSE DNA
$9.91 -0.10 (-1.00%)
As of: Oct 22, 2026 · 12:16 PM EDT

Ginkgo Bioworks Holdings (DNA) Debt Ratio (2020)

Updated

Ginkgo Bioworks Holdings' (DNA) Debt Ratio came in at 0.00 for Q4 2020.

Analysis

Ginkgo Bioworks Holdings (DNA) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Iqvia Holdings 46.14 Bn 37.84 Bn 1.44 Bn 0.54
2 Medpace Holdings 18.92 Bn 16.98 Bn 201.64 Mn -
3 Charles River Laboratories International 16.84 Bn 16.04 Bn 363.37 Mn 0.35
4 Icon 14.51 Bn 11.62 Bn 479.29 Mn 0.21
5 Fortrea Holdings 2.26 Bn 1.64 Bn 139.20 Mn 0.39
6 Ginkgo Bioworks Holdings 615.36 Mn -146.73 Mn 18.44 Mn -
7 Evotec SE 546.94 Mn -1.06 Bn - 0.30
8 Champions Oncology 68.86 Mn 43.95 Mn 7.70 Mn -
9 MindWalk Holdings 55.66 Mn 19.31 Mn 1.61 Mn -
10 Natural Alternatives International 7.23 Mn -20.85 Mn 1.73 Mn 0.15
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 0.00
API Access

Ginkgo Bioworks Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=DNA&period=max&api_key=YOUR_API_KEY